B. Riley Financial Varied

B. Riley Securities Presents Oncology Investor Conference on January 20-21, 2021

LOS ANGELES, January 20, 2021 — B. Riley Securities, Inc., a leading full-service investment bank and subsidiary of B. Riley Financial (NASDAQ: RILY) ("B. Riley"), today announced the list of presenting companies for B. Riley's Oncology Investor Conference taking place virtually on Wednesday, January 20 and Thursday, January 21, 2021.

Hosted by B. Riley's award-winning equity research team, this two-day event features several public and private healthcare companies on the cutting-edge of key oncology developments including cancer treatment, testing and monitoring modalities.

B. Riley's conference will also feature two panel discussions led by academic and industry R&D leaders pioneering translational research in novel immunotherapy and precision oncology approaches across hematological malignancies and solid tumors on Thursday, January 21:

  • "Hidden Gems in a Maturing Hematology-Oncology Therapeutic Landscape"
  • "Select Targets and Modalities Driving the Next Wave of Tranlational Immunotherapy Innovation"

List of Company Participants for B. Riley's Oncology Investor Conference

Wednesday, January 20, 2021


  • Accuray (ARAY)
  • Adastra Pharmaceuticals Inc.
  • Adicet Bio, Inc. (ACET)
  • AVEO Oncology (AVEO)
  • Clearpoint Neuro (CLPT)
  • EDAP TMS SA (EDAP)
  • F-star Therapeutics, Inc. (FSTX)
  • Geron Corp. (GERN)
  • iCAD, Inc. (ICAD)
  • IDEAYA Biosciences (IDYA)
  • Immatics N.V. (IMTX)
  • Infinity Pharmaceuticals, Inc. (INFI)
  • Intensity Therapeutics
  • Iovance Biotherapeutics, Inc. (IOVA)
  • Mosaic ImmunoEngineering
  • NGM Biopharmaceuticals, Inc. (NGM)
  • Purple Biotech Ltd. (PPBT)
  • Rafael Pharmaceuticals, Inc.
  • Sorrento Therapeutics, Inc. (SRNE)
  • TG Therapeutics, Inc. (TGTX)
  • Theratechnologies, Inc. (THTX)
  • ViewRay, Inc. (VRAY)
  • X4 Pharmaceuticals, Inc. (XFOR)
  • Zikani Therapeutics


Thursday, January 21, 2021


  • Actinium Pharmaceuticals, Inc. (ATNM)
  • Agenus Inc. (AGEN)
  • Aleta BioTherapeutics
  • Anixa Biosciences, Inc. (ANIX)
  • Celcuity Inc. (CELC)
  • Celularity Inc.
  • Checkpoint Therapeutics, Inc. (CKPT)
  • Compass Therapeutics, Inc.
  • Curis, Inc. (CRIS)
  • Genocea Biosciences, Inc. (GNCA)
  • Heat Biologics, Inc. (HTBX)
  • IN8bio, Inc.
  • Jubilant Therapeutics, Inc.
  • Kuur Therapeutics
  • Mustang Bio, Inc. (MBIO)
  • NEUVOGEN, Inc.
  • Pieris Pharmaceuticals (PIRS)
  • Privo Technologies
  • Puma Biotechnology, Inc. (PBYI)
  • Spectrum Pharmaceuticals, Inc. (SPPI)
  • Tiziana Life Sciences PLC (TLSA)
  • TRIGR Therapeutics, Inc.


Investors who are interested in registering for this event should contact their B. Riley representative.

For more information about B. Riley's proprietary events, including sponsorship opportunties, contact events@brileyfin.com.

In addition to B. Riley Securities, B. Riley Financial operates through several wholly owned subsidiaries, including: B. Riley Capital Management, an SEC-registered investment adviser, which provides advisory services to private funds; B. Riley Wealth Management, a FINRA-registered broker-dealer and member SIPC, which offers securities and variable insurance products; B. Riley Wealth Advisors, an SEC-registered investment adviser, which provides fee-based asset management and advisory services; B. Riley Wealth Portfolio Advisers, an SEC-registered investment adviser, which provides advisory and sub-advisory services, some through separately managed accounts using model portfolio; B. Riley Wealth Private Shares, an SEC-registered investment adviser, which provides advisory services to private funds; and B. Riley Principal Investments which makes proprietary investments in other businesses.

Copyright © 2024
B. Riley Financial all rights reserved.